Browsing by subject "Vaccination"
-
Cervical cancer screening in Australia: modelled evaluation of the impact of changing the recommended interval from two to three years
Published 2010ABSTRACT: BACKGROUND: The National Cervical Screening Program in Australia currently recommends that sexually active women between the ages of 18-70 years attend routine screening every 2 years. The publically funded ...Article -
The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
Published 2014BACKGROUND: The ARTISTIC (A Randomised Trial In Screening To Improve Cytology) trial originally reported after two rounds of primary cervical screening with human papillomavirus (HPV). Extended follow-up of the randomised ...Article -
Comparison of pre- and post-vaccination ovine Johne's disease prevalence using a Bayesian approach
Published 2013-01-01This study was conducted to evaluate the effectiveness of GudairTM vaccine in decreasing the prevalence of shedding of Mycobacterium avium subsp. paratuberculosis (MAP) in flocks of varying initial prevalence. Thirty seven ...Open AccessArticle -
Epidemiology and diagnosis of feline retroviruses (FIV and FeLV) in Australia and a trial of FIV vaccine effectiveness in the field.
Published 2016-10-20Feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) remain important infections of domestic cats in Australia and overseas. This thesis begins by providing up-to-date Australian prevalence data in three ...Open AccessThesis -
Estimation of cancer cases and deaths attributable to infection in China
Published 2011BACKGROUND: The burden of cancer attributable to infection in China has not been systematically quantified in detail. METHODS: Using the findings of systematic review of prevalence of infectious agents and their relative ...Article -
Evaluating Travel Behavior Resilience across Urban and Rural Areas during the COVID-19 Pandemic: Contributions of Vaccination and Epidemiological Indicators
Published 2023-08-22The COVID-19 pandemic has severely disrupted travel behavior across diverse socio-economic areas, with a significant impact on transportation systems, public health, and the economy. As countries both recover and plan for ...Open AccessWorking Paper -
Modeling preventative strategies against human papillomavirus-related disease in developed countries
Published 2012Over the last 5 years, prophylactic vaccination against human papillomavirus (HPV) in pre-adolescent females has been introduced in most developed countries, supported by modeled evaluations that have almost universally ...Article -
Models of cervical screening in the era of human papillomavirus vaccination
Published 2010Epidemiologic and economic evaluation using simulation modelling can support complex policy decisions, and is an important tool in predicting the future interaction between human papillomavirus vaccination and cervical ...Article -
Mucosal Vaccination with a Self-Adjuvanted Lipopeptide Is Immunogenic and Protective against Mycobacterium tuberculosis
Published 2019-08-02Tuberculosis (TB) remains a staggering burden on global public health. Novel preventative tools are desperately needed to reach the targets of the WHO post-2015 End-TB Strategy. Peptide or protein-based subunit vaccines ...Open AccessArticle -
Part II: Cancer in Indigenous Africans--causes and control
Published 2007Africa has contributed substantial knowledge to the understanding of certain risk factors for cancer, such as the role of several infectious agents (eg, viruses, bacteria, and parasites), aflatoxins, and certain lifestyle ...Article -
The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia
Published 2011Australia implemented a National HPV Vaccination Program in 2007, with routine vaccination of 12-13 year old females and catch-up in females aged 13-26 years to 2009. The aim of this study was to estimate the impact of the ...Article -
The predicted impact of vaccination on human papillomavirus infections in Australia
Published 2008Vaccines based on human papillomavirus (HPV) 16 and 18 virus-like particles have the potential to prevent approximately 70% of cervical cancers. In Australia, public vaccination against HPV commenced in April 2007, and ...Article -
Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies
Published 2011Comprehensive evaluation of the cost-effectiveness of HPV vaccination in China has not previously been performed. The objective of this study was to evaluate vaccination as an alternative or addition to primary HPV screening ...Article -
Q fever and Australia's veterinary workforce: research to inform vaccine policy.
Published 2021Q fever is a zoonotic disease of worldwide importance, causing significant and prolonged morbidity, low mortality, and burdening health systems with an enhanced requirement for diagnostics and disease surveillance. Most ...Open AccessThesis -
Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model
Published 2013BACKGROUND: Gardasil, a human papillomavirus (HPV) vaccine, began among grade 6 girls in Manitoba, Canada in 2008. In Manitoba, there is evidence that First Nations, Metis, and Inuit women (FNMI) have higher HPV prevalence, ...Open AccessArticle -
A revision of sexual mixing matrices in models of sexually transmitted infection
Published 2012Two sexual mixing matrices previously used in models of sexually transmitted infections (STIs) are intended to calculate the probability of sexual interaction between age groups and sexual behaviour subgroups. When these ...Open AccessArticle -
Time since first sexual intercourse and the risk of cervical cancer
Published 2012Young age at first sexual intercourse (AFI) is an important risk factor for cervical cancer, but no simple statistical model of its influence has been established. We investigated the relationship between risk of cervical ...Article -
Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand
Published 2013BACKGROUND: The national Human Papillomavirus (HPV) Immunisation Programme in New Zealand was introduced in 2008, and involves routine vaccination of girls 12-13 years with a catch-up for females aged up to 19 years. The ...Article